drugset / Trial / NCT05634577
A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma
NaSingle-groupOpen-labelTreatment
Summary
To learn if adding pembrolizumab to mitotane can help to control ACC. The safety of this drug combination will also be studied.
Timeline
- Start
- 2023-03-23
- Primary completion
- 2024-07-10
- Completion
- 2024-07-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mitotane | Small molecule | — | Oral |
| Subject | Pembrolizumab | Monoclonal antibody | — | Intravenous |